Download The Findit App

Share Your Posts On These Major Social Networks

Instatag Your Posts to Instagram Facebook + Twitter

News

Initiating Rare Disease Drug Discovery Projects

Dallas 9/3/2012 6:39:19 PM

In comparison with major diseases, the targeting of rare diseases poses many different challenges, necessitating consideration of bespoke R&D strategies for successful drug discovery efforts to be successful. This report examines the issue that need to be considered in the earliest stages of embarking on a rare disease project.

Features and benefits

  • Understand why rare diseases make attractive targets for launching new drug discovery projects.
  • Identify the key challenges that are presented by low patient prevalences.
  • Assess how the research strategy chosen can be influenced by the disease prevalence.
  • Understand the importance of considering issues of similarity versus other orphan drugs.
  • Compare the scenarios in which repurposing existing drugs offers advantages over the development of novel drugs, and vice versa.

Highlights

While disease prevalence has an impact on the commercial viability of a new treatment, returns are achievable even for ultra rare conditions. Rare diseases can provide sufficient opportunities for commercialization of multiple therapeutic agents. This is the case even for some ultra rare conditions such as Gaucher disease and Fabry disease.

Both clinical experts and patient groups provide valuable resources in understanding a rare disease and in identifying potential patients for clinical studies.

Many opportunities remain to develop treatments for untreated rare diseases. However, ultra rare diseases with high infant mortality present major challenges.

Your key questions answered

  • Can more than one drug be a commercial success for treating rare indications?
  • What are the best ways of identifying patients for recruitment into clinical trials?
  • Why it is necessary to consider logistic issues in planning clinical studies?
  • What are the requirements for a clinical candidate to treat a rare disease?
  • What factors determine whether a small-molecule or biologic strategy is most suitable? 

More News

Initiating Rare Disease Drug Discovery Projects


Released On: 9/3/2012
Views: 3429

Organic Light Emitting Diodes (OLEDs): Technologies and Global Markets


Released On: 9/3/2012
Views: 3117

2012 China Synthesis Polypeptide Drug Industry Market Research Report


Released On: 8/31/2012
Views: 3852

The Future of Coal Fired Power Generation Technologies


Released On: 8/27/2012
Views: 2953

Global and China Polyurethane Industry Chain Report, 2011-2012


Released On: 8/27/2012
Views: 2134

UK Commercial Property Insurance 2012


Released On: 8/27/2012
Views: 2827

IP Multimedia Subsystem (IMS) Solutions and Market Opportunities


Released On: 8/23/2012
Views: 2986

Personal Accident and Health Insurance in Hong Kong, Key Trends and Opportunities to 2016


Released On: 8/23/2012
Views: 2012

Graphene: Technologies, Applications and Markets: ReportsnReports


Released On: 8/21/2012
Views: 2703

Supraventricular Tachycardia (SVT) Therapeutics - Pipeline Assessment and Market Forecasts to 2019


Released On: 8/16/2012
Views: 3344

2012 Market Research Report on China Reversing Camera System Industry


Released On: 8/16/2012
Views: 1963

2012 Market Research Report on China Child Safety Seat Industry


Released On: 8/16/2012
Views: 4212

ReportsnReports: Agricultural Biotechnology: Emerging Technologies and Global Markets


Released On: 8/14/2012
Views: 2089

Clothing and footwear retail market in Russia 2012


Released On: 8/14/2012
Views: 1907

Clothing and footwear retail market in Poland 2012: ReportsnReports


Released On: 8/14/2012
Views: 1792

Cement market in CIS countries 2012


Released On: 8/13/2012
Views: 2201

Personal Accident and Health Insurance in the Netherlands, Key Trends and Opportunities to 2016


Released On: 8/13/2012
Views: 2091

U.S. Indoor Air Quality Market


Released On: 8/13/2012
Views: 1941

Load More wait